TAP Block vs Spinal Orphine for Postoperative Caesarean Section Analgetics
NCT ID: NCT06089200
Last Updated: 2023-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
44 participants
INTERVENTIONAL
2023-02-23
2023-04-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Which post op analgesic method works better for patients who underwent caesarean section
* The number of additional opioid needed
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Bilateral Ultrasound-Guided TAP Block on Quality of Recovery in Cesarean Delivery Patients Receiving Intrathecal Morphine
NCT07145619
Transversus Abdominis Plane Block Versus Spinal Morphine After Caesarean Section : A Comparison Study
NCT03263689
Comparison of Two Types of Pain Relief After Cesarean Delivery
NCT01151943
Tap Block and Cesarean Delivery: Efficacy and Consumption of Postoperative Drugs
NCT02801968
Postoperative Analgesic Efficacy of Trans Abdominis Plane Block
NCT05831501
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transversus Abdominis Plane Block
Twenty two subjects were given postoperative block administration in the transversus abdominis area on each side with ultrasonography (USG) guidance
Transversus Abdominal Plane Block
20 cc of bupivacaine 0.2% was given to the transversus abdominis plane
Spinal Morphine
Twenty two subjects were given additional morphine 100 µg intrathecally
Spinal Morphine
100 µg was administered intrathecally preoperatively
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transversus Abdominal Plane Block
20 cc of bupivacaine 0.2% was given to the transversus abdominis plane
Spinal Morphine
100 µg was administered intrathecally preoperatively
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA II
* Consented to be included in the study
Exclusion Criteria
* Spinal converted to general anesthesia
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitas Padjadjaran
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohammad F Maulana, MD
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine Universitas Padjadjaran Bandung
Suwarman, MD
Role: STUDY_DIRECTOR
Faculty of Medicine Universitas Padjadjaran Bandung
Osmond M Pison, MD
Role: STUDY_DIRECTOR
Faculty of Medicine Universitas Padjadjaran Bandung
Prapanca Nugraha, MD
Role: STUDY_DIRECTOR
Faculty of Medicine Universitas Padjadjaran Bandung
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hasan Sadikin General Hospital
Bandung, West Java, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AN-202310.01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.